Brainstorm Cell Therapeutics Inc. BCLI
0.97
0.02
2.11%
as of 25 Sep
- Market cap
- $7.0M
- P/E
- 0.0×
Follow BCLI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.03 | 0.04 | 0.24 | 0.35 | 3.69 | 3.85 | 0.19 | 1.65 | 1.74 | 12.09 |
Net Debt/EBITDA |
(0.10) | (0.01) | 0.06 | 0.06 | 0.85 | 1.25 | (0.03) | 0.51 | 1.58 | 2.29 |
Debt/Assets |
94.62% | 16.38% | 0.00% | 16.89% | 4.99% | 5.18% | 19.33% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.10) | (0.04) | 0.00 | (0.47) | 0.08 | 0.07 | (0.10) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.68 | 0.78 | 1.19 | 0.80 | 1.07 | 1.11 | 0.48 | 0.89 | 0.48 | 1.18 |
Capex/Depreciation |
0.00 | 0.05 | (0.07) | (0.10) | (1.27) | (1.73) | (2.88) | (3.35) | (2.12) | (0.14) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 116.14% | 184.17% | 436.73% | (297.38%) | (89.25%) | (273.75%) | 645.29% | (256.02%) | (62.76%) | (41.46%) | |
| (722.28%) | (384.87%) | (271.62%) | (128.69%) | (60.74%) | (110.09%) | (261.83%) | (123.16%) | (44.63%) | (35.78%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
98.49% | 142.46% | 329.66% | 509.91% | (134.73%) | (96.02%) | 174.39% | (296.20%) | (110.73%) | (50.44%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.75) | (1.81) | (7.13) | (7.95) | (11.02) | (17.87) | (8.02) | (9.56) | (2.03) | (4.79) |
Cash per Share |
0.00 | 0.04 | 0.45 | 1.23 | 9.16 | 21.06 | 0.39 | 5.30 | 6.19 | 8.03 |
Shareholders Equity per Share |
(1.08) | (1.55) | (1.69) | (1.24) | 8.01 | 17.81 | (8.37) | 3.76 | 4.70 | 7.95 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(1.08) | (1.55) | (1.69) | (1.24) | 8.01 | 17.81 | (8.37) | 3.76 | 4.70 | 7.95 |
Free Cash Flow |
(6.97) | (9.08) | (20.48) | (19.35) | (26.59) | (35.57) | (11.72) | (12.76) | (2.54) | (5.96) |
Working Capital |
(10.70) | (8.59) | (5.90) | (5.69) | 16.96 | 32.01 | (14.29) | 4.06 | 4.08 | 9.58 |
Capital Expenditures |
— | 0.01 | (0.02) | (0.03) | (0.33) | (0.38) | (0.47) | (0.37) | (0.18) | (0.10) |
Net Current Asset Value |
(10.70) | (9.21) | (7.17) | (8.36) | 13.35 | 27.45 | (15.40) | 4.06 | 4.08 | 9.58 |
| Other line items | ||||||||||
Quick Ratio |
0.01 | 0.03 | 0.17 | 0.35 | 3.51 | 3.76 | 0.17 | 1.46 | 1.52 | 11.92 |
Depreciation/Fixed assets |
0.85 | 0.55 | 0.39 | 0.31 | 0.22 | 0.20 | 0.17 | 0.17 | 0.22 | 2.40 |
Cash ROIC |
80.21% | 130.92% | 594.27% | (1,451.83%) | (64.00%) | (45.36%) | 117.48% | (107.94%) | (20.21%) | (30.94%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.75) | (1.81) | (7.12) | (7.93) | (10.88) | (17.68) | (7.70) | (9.29) | (1.89) | (4.71) |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | (0.14) | (0.19) | (0.32) | (0.28) | (0.14) | (0.08) |
Average Receivables |
0.07 | 0.06 | 0.07 | 0.09 | 0.20 | 1.33 | 2.18 | 1.34 | 0.49 | 0.53 |
Average Payables |
6.57 | 5.52 | 5.59 | 4.96 | 4.56 | 10.05 | 9.61 | 2.99 | 0.88 | 0.76 |
Average Assets |
1.43 | 3.02 | 6.33 | 18.86 | 40.27 | 28.90 | 8.88 | 11.33 | 11.09 | 13.92 |
Average Common Equity |
(8.87) | (6.31) | (3.94) | 8.16 | 27.40 | 11.62 | (3.60) | 5.45 | 7.89 | 12.02 |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates